User profiles for William HK Schilling
 | William HK SchillingMahidol Oxford Tropical Medicine Research Unit Verified email at tropmedres.ac Cited by 238 |
[HTML][HTML] Blood culture negative endocarditis in the modern era of 16S rRNA sequencing
R Godfrey, S Curtis, WHK Schilling, PR James - Clinical Medicine, 2020 - ncbi.nlm.nih.gov
Blood culture negative endocarditis (BCNE) accounts for up to 20% of infective endocarditis.
While the most common cause of BCNE remains the initiation of antibiotics prior to culture, …
While the most common cause of BCNE remains the initiation of antibiotics prior to culture, …
Chronic osteomyelitis: a review on current concepts and trends in treatment
Osteomyelitis is a complex and potentially devastating condition. Appropriate therapy
requires a multimodal orthoplastic approach and the cornerstone of treatment is surgical …
requires a multimodal orthoplastic approach and the cornerstone of treatment is surgical …
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
S Singh, S Boyd, WHK Schilling… - Journal of …, 2024 - academic.oup.com
Background Effective antiviral drugs accelerate viral clearance in acute COVID-19 infections;
the relationship between accelerating viral clearance and reducing severe clinical …
the relationship between accelerating viral clearance and reducing severe clinical …
[HTML][HTML] Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2 …
WHK Schilling, P Jittamala, JA Watson… - The Lancet Infectious …, 2024 - thelancet.com
Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …
antiviral treatments, but their antiviral activities in patients have not been compared …
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)
P Jittamala, WHK Schilling, JA Watson… - The Journal of …, 2023 - academic.oup.com
Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
[HTML][HTML] Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
V Luvira, WHK Schilling, P Jittamala, JA Watson… - BMC Infectious …, 2024 - Springer
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
WHK Schilling, P Jittamala, JA Watson… - ELife, 2023 - elifesciences.org
Background: There is no generally accepted methodology for in vivo assessment of antiviral
activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment …
activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment …
[HTML][HTML] Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis …
P Wongnak, WHK Schilling, P Jittamala… - The Lancet Infectious …, 2024 - thelancet.com
Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
[HTML][HTML] Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
…, M Richard-Greenblatt, WHK Schilling… - Wellcome open …, 2021 - ncbi.nlm.nih.gov
In rural areas of South and Southeast Asia malaria is declining but febrile illnesses still account
for substantial morbidity and mortality. Village health workers (VHWs) are often the first …
for substantial morbidity and mortality. Village health workers (VHWs) are often the first …
Does hydroxychloroquine still have any role in the COVID-19 pandemic?
WHK Schilling, NJ White - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction: The 4-aminoquinolines, chloroquine, and hydroxychloroquine have been used
for over 70 years for malaria and rheumatological conditions, respectively. Their broad-…
for over 70 years for malaria and rheumatological conditions, respectively. Their broad-…
